The significance of an increase in ALT in metabolically-caused fatty liver disease cannot be attested to a good predictive power with regard to NAFL or fibrosis, and thus a diagnosis based on these laboratory values cannot be valid. This evidence concerns the gene GPT and fatty liver disease.